131 related articles for article (PubMed ID: 11712177)
1. New structural and functional properties of fibrinogen and its early homologue, fragment X.
Rozenfel'd MA; Kostanova EA; Vasil'eva MV; Leonova VB
Dokl Biochem Biophys; 2001; 378():191-4. PubMed ID: 11712177
[No Abstract] [Full Text] [Related]
2. [Influence of end products of plasmin-mediated hydrolysis of fibrinogen and fibrin (EF and Ef fragments) on fibrinogen cross-linking].
Leonova VB; Rozenfel'd MA; Biriukova MI; Kostanova EA; Vasil'eva MV
Izv Akad Nauk Ser Biol; 2002; (5):522-7. PubMed ID: 12400374
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of cross-linking of fibrinogen and its early structural homolog fragment X].
Rozenfel'd MA; Kostanova EA; Vasil'eva MV; Leonova VB
Izv Akad Nauk Ser Biol; 2001; (3):293-8. PubMed ID: 11433939
[TBL] [Abstract][Full Text] [Related]
4. The role of conformational domain lability of fibrinogen molecule in the processes of fibrin formation and fibrinolysis.
Rozenfel'd MA; Leonova VB; Biryukova MI
Dokl Biochem Biophys; 2006; 408():165-8. PubMed ID: 16913421
[No Abstract] [Full Text] [Related]
5. Position of gamma-chain carboxy-terminal regions in fibrinogen/fibrin cross-linking mixtures.
Siebenlist KR; Meh DA; Mosesson MW
Biochemistry; 2000 Nov; 39(46):14171-5. PubMed ID: 11087365
[TBL] [Abstract][Full Text] [Related]
6. Self-assembly of soluble unlinked and cross-linked fibrin oligomers.
Rosenfeld MA; Leonova VB; Biryukova MI; Vasileva MV
Biochemistry (Mosc); 2011 Oct; 76(10):1155-63. PubMed ID: 22098241
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-A resolution.
Madrazo J; Brown JH; Litvinovich S; Dominguez R; Yakovlev S; Medved L; Cohen C
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):11967-72. PubMed ID: 11593005
[TBL] [Abstract][Full Text] [Related]
8. [Effects of fibrinogen, fibrin and their degradation products on the behaviour of vascular smooth muscle cells].
Naito M
Nihon Ronen Igakkai Zasshi; 2000 Jun; 37(6):458-63. PubMed ID: 10998926
[TBL] [Abstract][Full Text] [Related]
9. The structure of soluble fibrin oligomers.
Rosenfeld MA; Leonova VB; Biryukova MI; Vasileva MV
Dokl Biochem Biophys; 2011; 440():203-6. PubMed ID: 22095118
[No Abstract] [Full Text] [Related]
10. Oxidized modification of fragments D and E from fibrinogen induced by ozone.
Rosenfeld MA; Leonova VB; Shchegolikhin AN; Razumovskii SD; Konstantinova ML; Bychkova AV; Kovarskii AL
Biochemistry (Mosc); 2010 Oct; 75(10):1285-93. PubMed ID: 21166647
[TBL] [Abstract][Full Text] [Related]
11. [The structural transformations of X-oligomers].
Rozenfel'd MA; Kostanova EA; Vasil'eva MV; Leonova VB
Izv Akad Nauk Ser Biol; 1999; (4):396-402. PubMed ID: 10520283
[TBL] [Abstract][Full Text] [Related]
12. Hydration of fibrinogen, fibrin, and fibrin degradation product (FDP) as estimated by nuclear magnetic resonance (NMR) spectroscopy.
Tanaka Y; Nakaya S; Yoshioka Y; Yoshida Y; Hanaoka H; Kawamura R; Yasuda N
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):243-9. PubMed ID: 1893057
[TBL] [Abstract][Full Text] [Related]
13. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
Rozenfel'd MA; Leonova VB; Khavkina LS
Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen assembly and crosslinking on a fibrin fragment E template.
Mosesson MW; Siebenlist KR; Hernandez I; Wall JS; Hainfeld JF
Thromb Haemost; 2002 Apr; 87(4):651-8. PubMed ID: 12008948
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of D-domain-containing specific inhibitors of polymerization on the fibrin self-assembly process].
Platonova TM; Chernyshenko TM; Sokolovs'ka LI
Ukr Biokhim Zh (1999); 2006; 78(3):124-9. PubMed ID: 17100320
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen Haifa: fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains.
Soria J; Soria C; Samama M; Tabori S; Kehl M; Henschen A; Nieuwenhuizen W; Rimon A; Tatarski I
Thromb Haemost; 1987 Jun; 57(3):310-3. PubMed ID: 2958955
[TBL] [Abstract][Full Text] [Related]
17. Abnormal fibrinogens with two structural defects.
Matsuda M; Terukina S; Yoshida N; Yamazumi K; Maekawa H
Adv Exp Med Biol; 1990; 281():63-72. PubMed ID: 2102626
[No Abstract] [Full Text] [Related]
18. [alphaC domains of fibrinogen molecules as the structures accelerating fibrin assembly].
Medved' LV; Gorkun OV; Maniakov VF; Belitser VA
Mol Biol (Mosk); 1986; 20(2):461-70. PubMed ID: 3702870
[TBL] [Abstract][Full Text] [Related]
19. The role of fibrinogen and related fragments in tumour angiogenesis and metastasis.
Staton CA; Brown NJ; Lewis CE
Expert Opin Biol Ther; 2003 Oct; 3(7):1105-20. PubMed ID: 14519075
[TBL] [Abstract][Full Text] [Related]
20. Do the isolated fibrinogen alphaC-domains form ordered oligomers?
Tsurupa G; Veklich Y; Hantgan R; Belkin AM; Weisel JW; Medved L
Biophys Chem; 2004 Dec; 112(2-3):257-66. PubMed ID: 15572257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
